FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144759405> ?p ?o ?g. }

• W2144759405 endingPage "3450" @default.
• W2144759405 startingPage "3440" @default.
• W2144759405 abstract "Numerous mechanisms of action have been proposed for intravenous Ig (IVIG). In this study, we used IgG passive transfer murine models of bullous pemphigoid (BP), pemphigus foliaceus (PF), and pemphigus vulgaris (PV) to test the hypothesis that the effect of IVIG in autoantibody-mediated cutaneous bullous diseases is to accelerate the degradation of pathogenic IgG by saturation of the MHC-like Fc receptor neonatal Fc receptor (FcRn). BP, PF, and PV are organ-specific antibody-mediated diseases in which autoantibodies target the hemidesmosomal antigen BP180 and desmosomal antigens Dsg1 and Dsg3, respectively. Antibodies against BP180, Dsg1, and Dsg3, when injected into neonatal mice, induce the BP, PF, and PV disease phenotypes, respectively. We found that FcRn-deficient mice were resistant to experimental BP, PF, and PV. Circulating levels of pathogenic IgG in FcRn-deficient mice were significantly reduced compared with those in WT mice. Administration of high-dose human IgG (HDIG) to WT mice also drastically reduced circulating pathogenic IgG levels and prevented blistering. In FcRn-deficient mice, no additional protective effect with HDIG was realized. These data demonstrate that the therapeutic efficacy of HDIG treatment in the pemphigus and pemphigoid models is dependent on FcRn. Thus, FcRn is a promising therapeutic target for treating such IgG-mediated autoimmune diseases." @default.
• W2144759405 created "2016-06-24" @default.
• W2144759405 creator A5018199914 @default.
• W2144759405 creator A5031810848 @default.
• W2144759405 creator A5042457188 @default.
• W2144759405 creator A5043433263 @default.
• W2144759405 creator A5050789569 @default.
• W2144759405 creator A5056400278 @default.
• W2144759405 creator A5063057273 @default.
• W2144759405 creator A5075875145 @default.
• W2144759405 date "2005-12-01" @default.
• W2144759405 modified "2023-10-07" @default.
• W2144759405 title "Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases" @default.
• W2144759405 cites W128685653 @default.
• W2144759405 cites W1520423634 @default.
• W2144759405 cites W1550465180 @default.
• W2144759405 cites W1578839038 @default.
• W2144759405 cites W1595284454 @default.
• W2144759405 cites W1669573844 @default.
• W2144759405 cites W1686249017 @default.
• W2144759405 cites W1926541123 @default.
• W2144759405 cites W1964180982 @default.
• W2144759405 cites W1972849586 @default.
• W2144759405 cites W1975466399 @default.
• W2144759405 cites W1975817555 @default.
• W2144759405 cites W1977067475 @default.
• W2144759405 cites W1983940041 @default.
• W2144759405 cites W198706224 @default.
• W2144759405 cites W1991027093 @default.
• W2144759405 cites W1995773407 @default.
• W2144759405 cites W1996497569 @default.
• W2144759405 cites W2002282183 @default.
• W2144759405 cites W2005838740 @default.
• W2144759405 cites W2007765706 @default.
• W2144759405 cites W2008638671 @default.
• W2144759405 cites W2009741791 @default.
• W2144759405 cites W2012967644 @default.
• W2144759405 cites W2019037591 @default.
• W2144759405 cites W2021030324 @default.
• W2144759405 cites W2025012298 @default.
• W2144759405 cites W2028627896 @default.
• W2144759405 cites W2030750387 @default.
• W2144759405 cites W2035159817 @default.
• W2144759405 cites W2044210749 @default.
• W2144759405 cites W2046603954 @default.
• W2144759405 cites W2048259741 @default.
• W2144759405 cites W2048954270 @default.
• W2144759405 cites W2050105110 @default.
• W2144759405 cites W2050148011 @default.
• W2144759405 cites W2052032023 @default.
• W2144759405 cites W2053257655 @default.
• W2144759405 cites W2064790068 @default.
• W2144759405 cites W2066862153 @default.
• W2144759405 cites W2071312755 @default.
• W2144759405 cites W2071614823 @default.
• W2144759405 cites W2073436919 @default.
• W2144759405 cites W2075689961 @default.
• W2144759405 cites W2076016542 @default.
• W2144759405 cites W2080704754 @default.
• W2144759405 cites W2081533497 @default.
• W2144759405 cites W2084469556 @default.
• W2144759405 cites W2088678446 @default.
• W2144759405 cites W2089440945 @default.
• W2144759405 cites W2095479698 @default.
• W2144759405 cites W2095788709 @default.
• W2144759405 cites W2110612065 @default.
• W2144759405 cites W2114995793 @default.
• W2144759405 cites W2116547757 @default.
• W2144759405 cites W2117761540 @default.
• W2144759405 cites W2126488951 @default.
• W2144759405 cites W2131558828 @default.
• W2144759405 cites W2138771248 @default.
• W2144759405 cites W2142709610 @default.
• W2144759405 cites W2145600010 @default.
• W2144759405 cites W2157037806 @default.
• W2144759405 cites W2159499933 @default.
• W2144759405 cites W2160343444 @default.
• W2144759405 cites W2160976069 @default.
• W2144759405 cites W2162864505 @default.
• W2144759405 cites W2166874143 @default.
• W2144759405 cites W2168376705 @default.
• W2144759405 cites W2169943386 @default.
• W2144759405 cites W2315610003 @default.
• W2144759405 cites W2616639792 @default.
• W2144759405 cites W3116890861 @default.
• W2144759405 cites W92943800 @default.
• W2144759405 doi "https://doi.org/10.1172/jci24394" @default.
• W2144759405 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1280965" @default.
• W2144759405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16284651" @default.
• W2144759405 hasPublicationYear "2005" @default.
• W2144759405 type Work @default.
• W2144759405 sameAs 2144759405 @default.
• W2144759405 citedByCount "227" @default.
• W2144759405 countsByYear W21447594052012 @default.
• W2144759405 countsByYear W21447594052013 @default.
• W2144759405 countsByYear W21447594052014 @default.
• W2144759405 countsByYear W21447594052015 @default.
• W2144759405 countsByYear W21447594052016 @default.

• next